Interstitial photodynamic therapy for malignant parotid tumours (IPG259)
Fast, easy summary view of NICE guidance on 'ear nose and throat conditions'
Fast, easy summary view of NICE guidance on 'head and neck cancer'
The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Interstitial photodynamic therapy for malignant parotid tumours in May 2008. In accordance with the Interventional Procedures Programme Process Guide, guidance on procedures with special arrangements are reviewed 3 years after publication and the procedure is reassessed if important new evidence is available.
The guidance was considered for reassessment in May 2010 and it was concluded that NICE will not be updating this guidance at this stage. However, if you believe there is new evidence which should warrant a review of our guidance, please contact us via the email address below.
The parotid glands are located in front of the ears and help to produce saliva. A tumour in a parotid gland usually causes a painless swelling on the side of the face where the affected gland is. Only a small number of these tumours are cancerous. In photodynamic therapy (usually abbreviated to PDT), a drug called a 'photosensitising agent' is injected into a vein. A few days later, needles are inserted into the tumour and a special light is shone through them. The light causes the photosensitising agent to destroy the tumour cells.
F45.5 Destruction of lesion of salivary gland
Y13.6 Photodynamic therapy of lesion of organ NOC
Z26.1 Parotid gland
In addition ICD-10 code C07. X Malignant neoplasm of parotid gland or C79.8 Secondary malignant neoplasm of other specified sites is assigned.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- Interstitial photodynamic therapy for malignant parotid tumours (interventional procedures consultation)
- Interstitial photodynamic therapy for malignant parotid tumours (interventional procedures overview)
- IPG259 Interstitial photodynamic therapy for malignant parotid tumours: Guidance
- IPG259 Interstitial photodynamic therapy for malignant parotid tumours: guidance (web format)
- IPG259 Interstitial photodynamic therapy for malignant parotid tumours: Understanding NICE guidance
- IPG259 Interstitial photodynamic therapy for malignant parotid tumours: Understanding NICE guidance (MS Word format)
- IPG259 Interstitial photodynamic therapy for malignant parotid tumours: Consultation comments
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
This page was last updated: 02 April 2014
- Web format
- Full Guidance (PDF)
- IPG259 Trin tiwmorau parotid malaen gan ddefnyddio therapi ffotodeinamig: deall canllawiau (fformat MS Word)
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.